Global Genetic Screening for Carrier Diseases Market 2024 by Company, Regions, Type and Application, Forecast to 2030
According to our (Global Info Research) latest study, the global Genetic Screening for Carrier Diseases market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
Genetic Screening for Carrier Diseases refers to detecting whether an individual carries the causative gene of a certain genetic disease. In human genetics, some diseases are caused by recessively inherited gene mutations. These mutations usually do not cause the disease in the individual themselves, but if two carriers have offspring, they may increase the risk of the offspring suffering from the genetic disease. Genetic screening for genetic disease carriers can help individuals, especially couples planning to have children, by helping to assess the risk of their future offspring developing specific genetic diseases. If both partners are carriers, they are more likely to have offspring with the disease. Through this screening, couples can better understand their genetic status, make more informed reproductive decisions, and seek genetic counseling and medical intervention when needed.
The Global Info Research report includes an overview of the development of the Genetic Screening for Carrier Diseases industry chain, the market status of Couple (NGS, Whole Exome Sequencing), Individual (NGS, Whole Exome Sequencing), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Genetic Screening for Carrier Diseases.
Regionally, the report analyzes the Genetic Screening for Carrier Diseases markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Genetic Screening for Carrier Diseases market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Genetic Screening for Carrier Diseases market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Genetic Screening for Carrier Diseases industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., NGS, Whole Exome Sequencing).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Genetic Screening for Carrier Diseases market.
Regional Analysis: The report involves examining the Genetic Screening for Carrier Diseases market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Genetic Screening for Carrier Diseases market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Genetic Screening for Carrier Diseases:
Company Analysis: Report covers individual Genetic Screening for Carrier Diseases players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Genetic Screening for Carrier Diseases This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Couple, Individual).
Technology Analysis: Report covers specific technologies relevant to Genetic Screening for Carrier Diseases. It assesses the current state, advancements, and potential future developments in Genetic Screening for Carrier Diseases areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Genetic Screening for Carrier Diseases market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Genetic Screening for Carrier Diseases market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Chapter 1, to describe Genetic Screening for Carrier Diseases product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Genetic Screening for Carrier Diseases, with revenue, gross margin and global market share of Genetic Screening for Carrier Diseases from 2019 to 2024.
Chapter 3, the Genetic Screening for Carrier Diseases competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Genetic Screening for Carrier Diseases market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Genetic Screening for Carrier Diseases.
Chapter 13, to describe Genetic Screening for Carrier Diseases research findings and conclusion.
Genetic Screening for Carrier Diseases refers to detecting whether an individual carries the causative gene of a certain genetic disease. In human genetics, some diseases are caused by recessively inherited gene mutations. These mutations usually do not cause the disease in the individual themselves, but if two carriers have offspring, they may increase the risk of the offspring suffering from the genetic disease. Genetic screening for genetic disease carriers can help individuals, especially couples planning to have children, by helping to assess the risk of their future offspring developing specific genetic diseases. If both partners are carriers, they are more likely to have offspring with the disease. Through this screening, couples can better understand their genetic status, make more informed reproductive decisions, and seek genetic counseling and medical intervention when needed.
The Global Info Research report includes an overview of the development of the Genetic Screening for Carrier Diseases industry chain, the market status of Couple (NGS, Whole Exome Sequencing), Individual (NGS, Whole Exome Sequencing), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Genetic Screening for Carrier Diseases.
Regionally, the report analyzes the Genetic Screening for Carrier Diseases markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Genetic Screening for Carrier Diseases market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Genetic Screening for Carrier Diseases market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Genetic Screening for Carrier Diseases industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., NGS, Whole Exome Sequencing).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Genetic Screening for Carrier Diseases market.
Regional Analysis: The report involves examining the Genetic Screening for Carrier Diseases market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Genetic Screening for Carrier Diseases market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Genetic Screening for Carrier Diseases:
Company Analysis: Report covers individual Genetic Screening for Carrier Diseases players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Genetic Screening for Carrier Diseases This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Couple, Individual).
Technology Analysis: Report covers specific technologies relevant to Genetic Screening for Carrier Diseases. It assesses the current state, advancements, and potential future developments in Genetic Screening for Carrier Diseases areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Genetic Screening for Carrier Diseases market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Genetic Screening for Carrier Diseases market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
- NGS
- Whole Exome Sequencing
- Others
- Couple
- Individual
- Thermo Fisher Scientific
- Eurofins Scientific
- Illumina
- Invitae
- MedGenome
- Myriad Genetics
- Roche
- Natera
- OPKO Health
- 23andMe
- bioMйrieux
- EKF Diagnostics
- Gene by Gene (myDNA)
- Fulgent Genetics
- NxGen MDx
- Sonic Genetics
- My Baby
- AncestryDNA
- DiaSorin
- Grifols
- BGI Genomics
- Chigene
- Jiajian Medical Testing
- Genesky
- Berry Genomics
- Weihansi Biomedical Technology
- Annaroad
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
- South America (Brazil, Argentina and Rest of South America)
- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter 1, to describe Genetic Screening for Carrier Diseases product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Genetic Screening for Carrier Diseases, with revenue, gross margin and global market share of Genetic Screening for Carrier Diseases from 2019 to 2024.
Chapter 3, the Genetic Screening for Carrier Diseases competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Genetic Screening for Carrier Diseases market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Genetic Screening for Carrier Diseases.
Chapter 13, to describe Genetic Screening for Carrier Diseases research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Genetic Screening for Carrier Diseases
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Genetic Screening for Carrier Diseases by Type
1.3.1 Overview: Global Genetic Screening for Carrier Diseases Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Genetic Screening for Carrier Diseases Consumption Value Market Share by Type in 2023
1.3.3 NGS
1.3.4 Whole Exome Sequencing
1.3.5 Others
1.4 Global Genetic Screening for Carrier Diseases Market by Application
1.4.1 Overview: Global Genetic Screening for Carrier Diseases Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Couple
1.4.3 Individual
1.5 Global Genetic Screening for Carrier Diseases Market Size & Forecast
1.6 Global Genetic Screening for Carrier Diseases Market Size and Forecast by Region
1.6.1 Global Genetic Screening for Carrier Diseases Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Genetic Screening for Carrier Diseases Market Size by Region, (2019-2030)
1.6.3 North America Genetic Screening for Carrier Diseases Market Size and Prospect (2019-2030)
1.6.4 Europe Genetic Screening for Carrier Diseases Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Genetic Screening for Carrier Diseases Market Size and Prospect (2019-2030)
1.6.6 South America Genetic Screening for Carrier Diseases Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Genetic Screening for Carrier Diseases Market Size and Prospect (2019-2030)
2 COMPANY PROFILES
2.1 Thermo Fisher Scientific
2.1.1 Thermo Fisher Scientific Details
2.1.2 Thermo Fisher Scientific Major Business
2.1.3 Thermo Fisher Scientific Genetic Screening for Carrier Diseases Product and Solutions
2.1.4 Thermo Fisher Scientific Genetic Screening for Carrier Diseases Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Thermo Fisher Scientific Recent Developments and Future Plans
2.2 Eurofins Scientific
2.2.1 Eurofins Scientific Details
2.2.2 Eurofins Scientific Major Business
2.2.3 Eurofins Scientific Genetic Screening for Carrier Diseases Product and Solutions
2.2.4 Eurofins Scientific Genetic Screening for Carrier Diseases Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Eurofins Scientific Recent Developments and Future Plans
2.3 Illumina
2.3.1 Illumina Details
2.3.2 Illumina Major Business
2.3.3 Illumina Genetic Screening for Carrier Diseases Product and Solutions
2.3.4 Illumina Genetic Screening for Carrier Diseases Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Illumina Recent Developments and Future Plans
2.4 Invitae
2.4.1 Invitae Details
2.4.2 Invitae Major Business
2.4.3 Invitae Genetic Screening for Carrier Diseases Product and Solutions
2.4.4 Invitae Genetic Screening for Carrier Diseases Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Invitae Recent Developments and Future Plans
2.5 MedGenome
2.5.1 MedGenome Details
2.5.2 MedGenome Major Business
2.5.3 MedGenome Genetic Screening for Carrier Diseases Product and Solutions
2.5.4 MedGenome Genetic Screening for Carrier Diseases Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 MedGenome Recent Developments and Future Plans
2.6 Myriad Genetics
2.6.1 Myriad Genetics Details
2.6.2 Myriad Genetics Major Business
2.6.3 Myriad Genetics Genetic Screening for Carrier Diseases Product and Solutions
2.6.4 Myriad Genetics Genetic Screening for Carrier Diseases Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Myriad Genetics Recent Developments and Future Plans
2.7 Roche
2.7.1 Roche Details
2.7.2 Roche Major Business
2.7.3 Roche Genetic Screening for Carrier Diseases Product and Solutions
2.7.4 Roche Genetic Screening for Carrier Diseases Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Roche Recent Developments and Future Plans
2.8 Natera
2.8.1 Natera Details
2.8.2 Natera Major Business
2.8.3 Natera Genetic Screening for Carrier Diseases Product and Solutions
2.8.4 Natera Genetic Screening for Carrier Diseases Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Natera Recent Developments and Future Plans
2.9 OPKO Health
2.9.1 OPKO Health Details
2.9.2 OPKO Health Major Business
2.9.3 OPKO Health Genetic Screening for Carrier Diseases Product and Solutions
2.9.4 OPKO Health Genetic Screening for Carrier Diseases Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 OPKO Health Recent Developments and Future Plans
2.10 23andMe
2.10.1 23andMe Details
2.10.2 23andMe Major Business
2.10.3 23andMe Genetic Screening for Carrier Diseases Product and Solutions
2.10.4 23andMe Genetic Screening for Carrier Diseases Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 23andMe Recent Developments and Future Plans
2.11 bioMйrieux
2.11.1 bioMйrieux Details
2.11.2 bioMйrieux Major Business
2.11.3 bioMйrieux Genetic Screening for Carrier Diseases Product and Solutions
2.11.4 bioMйrieux Genetic Screening for Carrier Diseases Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 bioMйrieux Recent Developments and Future Plans
2.12 EKF Diagnostics
2.12.1 EKF Diagnostics Details
2.12.2 EKF Diagnostics Major Business
2.12.3 EKF Diagnostics Genetic Screening for Carrier Diseases Product and Solutions
2.12.4 EKF Diagnostics Genetic Screening for Carrier Diseases Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 EKF Diagnostics Recent Developments and Future Plans
2.13 Gene by Gene (myDNA)
2.13.1 Gene by Gene (myDNA) Details
2.13.2 Gene by Gene (myDNA) Major Business
2.13.3 Gene by Gene (myDNA) Genetic Screening for Carrier Diseases Product and Solutions
2.13.4 Gene by Gene (myDNA) Genetic Screening for Carrier Diseases Revenue, Gross Margin and Market Share (2019-2024)
2.13.5 Gene by Gene (myDNA) Recent Developments and Future Plans
2.14 Fulgent Genetics
2.14.1 Fulgent Genetics Details
2.14.2 Fulgent Genetics Major Business
2.14.3 Fulgent Genetics Genetic Screening for Carrier Diseases Product and Solutions
2.14.4 Fulgent Genetics Genetic Screening for Carrier Diseases Revenue, Gross Margin and Market Share (2019-2024)
2.14.5 Fulgent Genetics Recent Developments and Future Plans
2.15 NxGen MDx
2.15.1 NxGen MDx Details
2.15.2 NxGen MDx Major Business
2.15.3 NxGen MDx Genetic Screening for Carrier Diseases Product and Solutions
2.15.4 NxGen MDx Genetic Screening for Carrier Diseases Revenue, Gross Margin and Market Share (2019-2024)
2.15.5 NxGen MDx Recent Developments and Future Plans
2.16 Sonic Genetics
2.16.1 Sonic Genetics Details
2.16.2 Sonic Genetics Major Business
2.16.3 Sonic Genetics Genetic Screening for Carrier Diseases Product and Solutions
2.16.4 Sonic Genetics Genetic Screening for Carrier Diseases Revenue, Gross Margin and Market Share (2019-2024)
2.16.5 Sonic Genetics Recent Developments and Future Plans
2.17 My Baby
2.17.1 My Baby Details
2.17.2 My Baby Major Business
2.17.3 My Baby Genetic Screening for Carrier Diseases Product and Solutions
2.17.4 My Baby Genetic Screening for Carrier Diseases Revenue, Gross Margin and Market Share (2019-2024)
2.17.5 My Baby Recent Developments and Future Plans
2.18 AncestryDNA
2.18.1 AncestryDNA Details
2.18.2 AncestryDNA Major Business
2.18.3 AncestryDNA Genetic Screening for Carrier Diseases Product and Solutions
2.18.4 AncestryDNA Genetic Screening for Carrier Diseases Revenue, Gross Margin and Market Share (2019-2024)
2.18.5 AncestryDNA Recent Developments and Future Plans
2.19 DiaSorin
2.19.1 DiaSorin Details
2.19.2 DiaSorin Major Business
2.19.3 DiaSorin Genetic Screening for Carrier Diseases Product and Solutions
2.19.4 DiaSorin Genetic Screening for Carrier Diseases Revenue, Gross Margin and Market Share (2019-2024)
2.19.5 DiaSorin Recent Developments and Future Plans
2.20 Grifols
2.20.1 Grifols Details
2.20.2 Grifols Major Business
2.20.3 Grifols Genetic Screening for Carrier Diseases Product and Solutions
2.20.4 Grifols Genetic Screening for Carrier Diseases Revenue, Gross Margin and Market Share (2019-2024)
2.20.5 Grifols Recent Developments and Future Plans
2.21 BGI Genomics
2.21.1 BGI Genomics Details
2.21.2 BGI Genomics Major Business
2.21.3 BGI Genomics Genetic Screening for Carrier Diseases Product and Solutions
2.21.4 BGI Genomics Genetic Screening for Carrier Diseases Revenue, Gross Margin and Market Share (2019-2024)
2.21.5 BGI Genomics Recent Developments and Future Plans
2.22 Chigene
2.22.1 Chigene Details
2.22.2 Chigene Major Business
2.22.3 Chigene Genetic Screening for Carrier Diseases Product and Solutions
2.22.4 Chigene Genetic Screening for Carrier Diseases Revenue, Gross Margin and Market Share (2019-2024)
2.22.5 Chigene Recent Developments and Future Plans
2.23 Jiajian Medical Testing
2.23.1 Jiajian Medical Testing Details
2.23.2 Jiajian Medical Testing Major Business
2.23.3 Jiajian Medical Testing Genetic Screening for Carrier Diseases Product and Solutions
2.23.4 Jiajian Medical Testing Genetic Screening for Carrier Diseases Revenue, Gross Margin and Market Share (2019-2024)
2.23.5 Jiajian Medical Testing Recent Developments and Future Plans
2.24 Genesky
2.24.1 Genesky Details
2.24.2 Genesky Major Business
2.24.3 Genesky Genetic Screening for Carrier Diseases Product and Solutions
2.24.4 Genesky Genetic Screening for Carrier Diseases Revenue, Gross Margin and Market Share (2019-2024)
2.24.5 Genesky Recent Developments and Future Plans
2.25 Berry Genomics
2.25.1 Berry Genomics Details
2.25.2 Berry Genomics Major Business
2.25.3 Berry Genomics Genetic Screening for Carrier Diseases Product and Solutions
2.25.4 Berry Genomics Genetic Screening for Carrier Diseases Revenue, Gross Margin and Market Share (2019-2024)
2.25.5 Berry Genomics Recent Developments and Future Plans
2.26 Weihansi Biomedical Technology
2.26.1 Weihansi Biomedical Technology Details
2.26.2 Weihansi Biomedical Technology Major Business
2.26.3 Weihansi Biomedical Technology Genetic Screening for Carrier Diseases Product and Solutions
2.26.4 Weihansi Biomedical Technology Genetic Screening for Carrier Diseases Revenue, Gross Margin and Market Share (2019-2024)
2.26.5 Weihansi Biomedical Technology Recent Developments and Future Plans
2.27 Annaroad
2.27.1 Annaroad Details
2.27.2 Annaroad Major Business
2.27.3 Annaroad Genetic Screening for Carrier Diseases Product and Solutions
2.27.4 Annaroad Genetic Screening for Carrier Diseases Revenue, Gross Margin and Market Share (2019-2024)
2.27.5 Annaroad Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Genetic Screening for Carrier Diseases Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Genetic Screening for Carrier Diseases by Company Revenue
3.2.2 Top 3 Genetic Screening for Carrier Diseases Players Market Share in 2023
3.2.3 Top 6 Genetic Screening for Carrier Diseases Players Market Share in 2023
3.3 Genetic Screening for Carrier Diseases Market: Overall Company Footprint Analysis
3.3.1 Genetic Screening for Carrier Diseases Market: Region Footprint
3.3.2 Genetic Screening for Carrier Diseases Market: Company Product Type Footprint
3.3.3 Genetic Screening for Carrier Diseases Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Genetic Screening for Carrier Diseases Consumption Value and Market Share by Type (2019-2024)
4.2 Global Genetic Screening for Carrier Diseases Market Forecast by Type (2025-2030)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Genetic Screening for Carrier Diseases Consumption Value Market Share by Application (2019-2024)
5.2 Global Genetic Screening for Carrier Diseases Market Forecast by Application (2025-2030)
6 NORTH AMERICA
6.1 North America Genetic Screening for Carrier Diseases Consumption Value by Type (2019-2030)
6.2 North America Genetic Screening for Carrier Diseases Consumption Value by Application (2019-2030)
6.3 North America Genetic Screening for Carrier Diseases Market Size by Country
6.3.1 North America Genetic Screening for Carrier Diseases Consumption Value by Country (2019-2030)
6.3.2 United States Genetic Screening for Carrier Diseases Market Size and Forecast (2019-2030)
6.3.3 Canada Genetic Screening for Carrier Diseases Market Size and Forecast (2019-2030)
6.3.4 Mexico Genetic Screening for Carrier Diseases Market Size and Forecast (2019-2030)
7 EUROPE
7.1 Europe Genetic Screening for Carrier Diseases Consumption Value by Type (2019-2030)
7.2 Europe Genetic Screening for Carrier Diseases Consumption Value by Application (2019-2030)
7.3 Europe Genetic Screening for Carrier Diseases Market Size by Country
7.3.1 Europe Genetic Screening for Carrier Diseases Consumption Value by Country (2019-2030)
7.3.2 Germany Genetic Screening for Carrier Diseases Market Size and Forecast (2019-2030)
7.3.3 France Genetic Screening for Carrier Diseases Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Genetic Screening for Carrier Diseases Market Size and Forecast (2019-2030)
7.3.5 Russia Genetic Screening for Carrier Diseases Market Size and Forecast (2019-2030)
7.3.6 Italy Genetic Screening for Carrier Diseases Market Size and Forecast (2019-2030)
8 ASIA-PACIFIC
8.1 Asia-Pacific Genetic Screening for Carrier Diseases Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Genetic Screening for Carrier Diseases Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Genetic Screening for Carrier Diseases Market Size by Region
8.3.1 Asia-Pacific Genetic Screening for Carrier Diseases Consumption Value by Region (2019-2030)
8.3.2 China Genetic Screening for Carrier Diseases Market Size and Forecast (2019-2030)
8.3.3 Japan Genetic Screening for Carrier Diseases Market Size and Forecast (2019-2030)
8.3.4 South Korea Genetic Screening for Carrier Diseases Market Size and Forecast (2019-2030)
8.3.5 India Genetic Screening for Carrier Diseases Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Genetic Screening for Carrier Diseases Market Size and Forecast (2019-2030)
8.3.7 Australia Genetic Screening for Carrier Diseases Market Size and Forecast (2019-2030)
9 SOUTH AMERICA
9.1 South America Genetic Screening for Carrier Diseases Consumption Value by Type (2019-2030)
9.2 South America Genetic Screening for Carrier Diseases Consumption Value by Application (2019-2030)
9.3 South America Genetic Screening for Carrier Diseases Market Size by Country
9.3.1 South America Genetic Screening for Carrier Diseases Consumption Value by Country (2019-2030)
9.3.2 Brazil Genetic Screening for Carrier Diseases Market Size and Forecast (2019-2030)
9.3.3 Argentina Genetic Screening for Carrier Diseases Market Size and Forecast (2019-2030)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Genetic Screening for Carrier Diseases Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Genetic Screening for Carrier Diseases Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Genetic Screening for Carrier Diseases Market Size by Country
10.3.1 Middle East & Africa Genetic Screening for Carrier Diseases Consumption Value by Country (2019-2030)
10.3.2 Turkey Genetic Screening for Carrier Diseases Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Genetic Screening for Carrier Diseases Market Size and Forecast (2019-2030)
10.3.4 UAE Genetic Screening for Carrier Diseases Market Size and Forecast (2019-2030)
11 MARKET DYNAMICS
11.1 Genetic Screening for Carrier Diseases Market Drivers
11.2 Genetic Screening for Carrier Diseases Market Restraints
11.3 Genetic Screening for Carrier Diseases Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Genetic Screening for Carrier Diseases Industry Chain
12.2 Genetic Screening for Carrier Diseases Upstream Analysis
12.3 Genetic Screening for Carrier Diseases Midstream Analysis
12.4 Genetic Screening for Carrier Diseases Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope of Genetic Screening for Carrier Diseases
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Genetic Screening for Carrier Diseases by Type
1.3.1 Overview: Global Genetic Screening for Carrier Diseases Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Genetic Screening for Carrier Diseases Consumption Value Market Share by Type in 2023
1.3.3 NGS
1.3.4 Whole Exome Sequencing
1.3.5 Others
1.4 Global Genetic Screening for Carrier Diseases Market by Application
1.4.1 Overview: Global Genetic Screening for Carrier Diseases Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Couple
1.4.3 Individual
1.5 Global Genetic Screening for Carrier Diseases Market Size & Forecast
1.6 Global Genetic Screening for Carrier Diseases Market Size and Forecast by Region
1.6.1 Global Genetic Screening for Carrier Diseases Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Genetic Screening for Carrier Diseases Market Size by Region, (2019-2030)
1.6.3 North America Genetic Screening for Carrier Diseases Market Size and Prospect (2019-2030)
1.6.4 Europe Genetic Screening for Carrier Diseases Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Genetic Screening for Carrier Diseases Market Size and Prospect (2019-2030)
1.6.6 South America Genetic Screening for Carrier Diseases Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Genetic Screening for Carrier Diseases Market Size and Prospect (2019-2030)
2 COMPANY PROFILES
2.1 Thermo Fisher Scientific
2.1.1 Thermo Fisher Scientific Details
2.1.2 Thermo Fisher Scientific Major Business
2.1.3 Thermo Fisher Scientific Genetic Screening for Carrier Diseases Product and Solutions
2.1.4 Thermo Fisher Scientific Genetic Screening for Carrier Diseases Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Thermo Fisher Scientific Recent Developments and Future Plans
2.2 Eurofins Scientific
2.2.1 Eurofins Scientific Details
2.2.2 Eurofins Scientific Major Business
2.2.3 Eurofins Scientific Genetic Screening for Carrier Diseases Product and Solutions
2.2.4 Eurofins Scientific Genetic Screening for Carrier Diseases Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Eurofins Scientific Recent Developments and Future Plans
2.3 Illumina
2.3.1 Illumina Details
2.3.2 Illumina Major Business
2.3.3 Illumina Genetic Screening for Carrier Diseases Product and Solutions
2.3.4 Illumina Genetic Screening for Carrier Diseases Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Illumina Recent Developments and Future Plans
2.4 Invitae
2.4.1 Invitae Details
2.4.2 Invitae Major Business
2.4.3 Invitae Genetic Screening for Carrier Diseases Product and Solutions
2.4.4 Invitae Genetic Screening for Carrier Diseases Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Invitae Recent Developments and Future Plans
2.5 MedGenome
2.5.1 MedGenome Details
2.5.2 MedGenome Major Business
2.5.3 MedGenome Genetic Screening for Carrier Diseases Product and Solutions
2.5.4 MedGenome Genetic Screening for Carrier Diseases Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 MedGenome Recent Developments and Future Plans
2.6 Myriad Genetics
2.6.1 Myriad Genetics Details
2.6.2 Myriad Genetics Major Business
2.6.3 Myriad Genetics Genetic Screening for Carrier Diseases Product and Solutions
2.6.4 Myriad Genetics Genetic Screening for Carrier Diseases Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Myriad Genetics Recent Developments and Future Plans
2.7 Roche
2.7.1 Roche Details
2.7.2 Roche Major Business
2.7.3 Roche Genetic Screening for Carrier Diseases Product and Solutions
2.7.4 Roche Genetic Screening for Carrier Diseases Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Roche Recent Developments and Future Plans
2.8 Natera
2.8.1 Natera Details
2.8.2 Natera Major Business
2.8.3 Natera Genetic Screening for Carrier Diseases Product and Solutions
2.8.4 Natera Genetic Screening for Carrier Diseases Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Natera Recent Developments and Future Plans
2.9 OPKO Health
2.9.1 OPKO Health Details
2.9.2 OPKO Health Major Business
2.9.3 OPKO Health Genetic Screening for Carrier Diseases Product and Solutions
2.9.4 OPKO Health Genetic Screening for Carrier Diseases Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 OPKO Health Recent Developments and Future Plans
2.10 23andMe
2.10.1 23andMe Details
2.10.2 23andMe Major Business
2.10.3 23andMe Genetic Screening for Carrier Diseases Product and Solutions
2.10.4 23andMe Genetic Screening for Carrier Diseases Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 23andMe Recent Developments and Future Plans
2.11 bioMйrieux
2.11.1 bioMйrieux Details
2.11.2 bioMйrieux Major Business
2.11.3 bioMйrieux Genetic Screening for Carrier Diseases Product and Solutions
2.11.4 bioMйrieux Genetic Screening for Carrier Diseases Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 bioMйrieux Recent Developments and Future Plans
2.12 EKF Diagnostics
2.12.1 EKF Diagnostics Details
2.12.2 EKF Diagnostics Major Business
2.12.3 EKF Diagnostics Genetic Screening for Carrier Diseases Product and Solutions
2.12.4 EKF Diagnostics Genetic Screening for Carrier Diseases Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 EKF Diagnostics Recent Developments and Future Plans
2.13 Gene by Gene (myDNA)
2.13.1 Gene by Gene (myDNA) Details
2.13.2 Gene by Gene (myDNA) Major Business
2.13.3 Gene by Gene (myDNA) Genetic Screening for Carrier Diseases Product and Solutions
2.13.4 Gene by Gene (myDNA) Genetic Screening for Carrier Diseases Revenue, Gross Margin and Market Share (2019-2024)
2.13.5 Gene by Gene (myDNA) Recent Developments and Future Plans
2.14 Fulgent Genetics
2.14.1 Fulgent Genetics Details
2.14.2 Fulgent Genetics Major Business
2.14.3 Fulgent Genetics Genetic Screening for Carrier Diseases Product and Solutions
2.14.4 Fulgent Genetics Genetic Screening for Carrier Diseases Revenue, Gross Margin and Market Share (2019-2024)
2.14.5 Fulgent Genetics Recent Developments and Future Plans
2.15 NxGen MDx
2.15.1 NxGen MDx Details
2.15.2 NxGen MDx Major Business
2.15.3 NxGen MDx Genetic Screening for Carrier Diseases Product and Solutions
2.15.4 NxGen MDx Genetic Screening for Carrier Diseases Revenue, Gross Margin and Market Share (2019-2024)
2.15.5 NxGen MDx Recent Developments and Future Plans
2.16 Sonic Genetics
2.16.1 Sonic Genetics Details
2.16.2 Sonic Genetics Major Business
2.16.3 Sonic Genetics Genetic Screening for Carrier Diseases Product and Solutions
2.16.4 Sonic Genetics Genetic Screening for Carrier Diseases Revenue, Gross Margin and Market Share (2019-2024)
2.16.5 Sonic Genetics Recent Developments and Future Plans
2.17 My Baby
2.17.1 My Baby Details
2.17.2 My Baby Major Business
2.17.3 My Baby Genetic Screening for Carrier Diseases Product and Solutions
2.17.4 My Baby Genetic Screening for Carrier Diseases Revenue, Gross Margin and Market Share (2019-2024)
2.17.5 My Baby Recent Developments and Future Plans
2.18 AncestryDNA
2.18.1 AncestryDNA Details
2.18.2 AncestryDNA Major Business
2.18.3 AncestryDNA Genetic Screening for Carrier Diseases Product and Solutions
2.18.4 AncestryDNA Genetic Screening for Carrier Diseases Revenue, Gross Margin and Market Share (2019-2024)
2.18.5 AncestryDNA Recent Developments and Future Plans
2.19 DiaSorin
2.19.1 DiaSorin Details
2.19.2 DiaSorin Major Business
2.19.3 DiaSorin Genetic Screening for Carrier Diseases Product and Solutions
2.19.4 DiaSorin Genetic Screening for Carrier Diseases Revenue, Gross Margin and Market Share (2019-2024)
2.19.5 DiaSorin Recent Developments and Future Plans
2.20 Grifols
2.20.1 Grifols Details
2.20.2 Grifols Major Business
2.20.3 Grifols Genetic Screening for Carrier Diseases Product and Solutions
2.20.4 Grifols Genetic Screening for Carrier Diseases Revenue, Gross Margin and Market Share (2019-2024)
2.20.5 Grifols Recent Developments and Future Plans
2.21 BGI Genomics
2.21.1 BGI Genomics Details
2.21.2 BGI Genomics Major Business
2.21.3 BGI Genomics Genetic Screening for Carrier Diseases Product and Solutions
2.21.4 BGI Genomics Genetic Screening for Carrier Diseases Revenue, Gross Margin and Market Share (2019-2024)
2.21.5 BGI Genomics Recent Developments and Future Plans
2.22 Chigene
2.22.1 Chigene Details
2.22.2 Chigene Major Business
2.22.3 Chigene Genetic Screening for Carrier Diseases Product and Solutions
2.22.4 Chigene Genetic Screening for Carrier Diseases Revenue, Gross Margin and Market Share (2019-2024)
2.22.5 Chigene Recent Developments and Future Plans
2.23 Jiajian Medical Testing
2.23.1 Jiajian Medical Testing Details
2.23.2 Jiajian Medical Testing Major Business
2.23.3 Jiajian Medical Testing Genetic Screening for Carrier Diseases Product and Solutions
2.23.4 Jiajian Medical Testing Genetic Screening for Carrier Diseases Revenue, Gross Margin and Market Share (2019-2024)
2.23.5 Jiajian Medical Testing Recent Developments and Future Plans
2.24 Genesky
2.24.1 Genesky Details
2.24.2 Genesky Major Business
2.24.3 Genesky Genetic Screening for Carrier Diseases Product and Solutions
2.24.4 Genesky Genetic Screening for Carrier Diseases Revenue, Gross Margin and Market Share (2019-2024)
2.24.5 Genesky Recent Developments and Future Plans
2.25 Berry Genomics
2.25.1 Berry Genomics Details
2.25.2 Berry Genomics Major Business
2.25.3 Berry Genomics Genetic Screening for Carrier Diseases Product and Solutions
2.25.4 Berry Genomics Genetic Screening for Carrier Diseases Revenue, Gross Margin and Market Share (2019-2024)
2.25.5 Berry Genomics Recent Developments and Future Plans
2.26 Weihansi Biomedical Technology
2.26.1 Weihansi Biomedical Technology Details
2.26.2 Weihansi Biomedical Technology Major Business
2.26.3 Weihansi Biomedical Technology Genetic Screening for Carrier Diseases Product and Solutions
2.26.4 Weihansi Biomedical Technology Genetic Screening for Carrier Diseases Revenue, Gross Margin and Market Share (2019-2024)
2.26.5 Weihansi Biomedical Technology Recent Developments and Future Plans
2.27 Annaroad
2.27.1 Annaroad Details
2.27.2 Annaroad Major Business
2.27.3 Annaroad Genetic Screening for Carrier Diseases Product and Solutions
2.27.4 Annaroad Genetic Screening for Carrier Diseases Revenue, Gross Margin and Market Share (2019-2024)
2.27.5 Annaroad Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Genetic Screening for Carrier Diseases Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Genetic Screening for Carrier Diseases by Company Revenue
3.2.2 Top 3 Genetic Screening for Carrier Diseases Players Market Share in 2023
3.2.3 Top 6 Genetic Screening for Carrier Diseases Players Market Share in 2023
3.3 Genetic Screening for Carrier Diseases Market: Overall Company Footprint Analysis
3.3.1 Genetic Screening for Carrier Diseases Market: Region Footprint
3.3.2 Genetic Screening for Carrier Diseases Market: Company Product Type Footprint
3.3.3 Genetic Screening for Carrier Diseases Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Genetic Screening for Carrier Diseases Consumption Value and Market Share by Type (2019-2024)
4.2 Global Genetic Screening for Carrier Diseases Market Forecast by Type (2025-2030)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Genetic Screening for Carrier Diseases Consumption Value Market Share by Application (2019-2024)
5.2 Global Genetic Screening for Carrier Diseases Market Forecast by Application (2025-2030)
6 NORTH AMERICA
6.1 North America Genetic Screening for Carrier Diseases Consumption Value by Type (2019-2030)
6.2 North America Genetic Screening for Carrier Diseases Consumption Value by Application (2019-2030)
6.3 North America Genetic Screening for Carrier Diseases Market Size by Country
6.3.1 North America Genetic Screening for Carrier Diseases Consumption Value by Country (2019-2030)
6.3.2 United States Genetic Screening for Carrier Diseases Market Size and Forecast (2019-2030)
6.3.3 Canada Genetic Screening for Carrier Diseases Market Size and Forecast (2019-2030)
6.3.4 Mexico Genetic Screening for Carrier Diseases Market Size and Forecast (2019-2030)
7 EUROPE
7.1 Europe Genetic Screening for Carrier Diseases Consumption Value by Type (2019-2030)
7.2 Europe Genetic Screening for Carrier Diseases Consumption Value by Application (2019-2030)
7.3 Europe Genetic Screening for Carrier Diseases Market Size by Country
7.3.1 Europe Genetic Screening for Carrier Diseases Consumption Value by Country (2019-2030)
7.3.2 Germany Genetic Screening for Carrier Diseases Market Size and Forecast (2019-2030)
7.3.3 France Genetic Screening for Carrier Diseases Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Genetic Screening for Carrier Diseases Market Size and Forecast (2019-2030)
7.3.5 Russia Genetic Screening for Carrier Diseases Market Size and Forecast (2019-2030)
7.3.6 Italy Genetic Screening for Carrier Diseases Market Size and Forecast (2019-2030)
8 ASIA-PACIFIC
8.1 Asia-Pacific Genetic Screening for Carrier Diseases Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Genetic Screening for Carrier Diseases Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Genetic Screening for Carrier Diseases Market Size by Region
8.3.1 Asia-Pacific Genetic Screening for Carrier Diseases Consumption Value by Region (2019-2030)
8.3.2 China Genetic Screening for Carrier Diseases Market Size and Forecast (2019-2030)
8.3.3 Japan Genetic Screening for Carrier Diseases Market Size and Forecast (2019-2030)
8.3.4 South Korea Genetic Screening for Carrier Diseases Market Size and Forecast (2019-2030)
8.3.5 India Genetic Screening for Carrier Diseases Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Genetic Screening for Carrier Diseases Market Size and Forecast (2019-2030)
8.3.7 Australia Genetic Screening for Carrier Diseases Market Size and Forecast (2019-2030)
9 SOUTH AMERICA
9.1 South America Genetic Screening for Carrier Diseases Consumption Value by Type (2019-2030)
9.2 South America Genetic Screening for Carrier Diseases Consumption Value by Application (2019-2030)
9.3 South America Genetic Screening for Carrier Diseases Market Size by Country
9.3.1 South America Genetic Screening for Carrier Diseases Consumption Value by Country (2019-2030)
9.3.2 Brazil Genetic Screening for Carrier Diseases Market Size and Forecast (2019-2030)
9.3.3 Argentina Genetic Screening for Carrier Diseases Market Size and Forecast (2019-2030)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Genetic Screening for Carrier Diseases Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Genetic Screening for Carrier Diseases Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Genetic Screening for Carrier Diseases Market Size by Country
10.3.1 Middle East & Africa Genetic Screening for Carrier Diseases Consumption Value by Country (2019-2030)
10.3.2 Turkey Genetic Screening for Carrier Diseases Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Genetic Screening for Carrier Diseases Market Size and Forecast (2019-2030)
10.3.4 UAE Genetic Screening for Carrier Diseases Market Size and Forecast (2019-2030)
11 MARKET DYNAMICS
11.1 Genetic Screening for Carrier Diseases Market Drivers
11.2 Genetic Screening for Carrier Diseases Market Restraints
11.3 Genetic Screening for Carrier Diseases Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Genetic Screening for Carrier Diseases Industry Chain
12.2 Genetic Screening for Carrier Diseases Upstream Analysis
12.3 Genetic Screening for Carrier Diseases Midstream Analysis
12.4 Genetic Screening for Carrier Diseases Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global Genetic Screening for Carrier Diseases Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Genetic Screening for Carrier Diseases Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Global Genetic Screening for Carrier Diseases Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global Genetic Screening for Carrier Diseases Consumption Value by Region (2025-2030) & (USD Million)
Table 5. Thermo Fisher Scientific Company Information, Head Office, and Major Competitors
Table 6. Thermo Fisher Scientific Major Business
Table 7. Thermo Fisher Scientific Genetic Screening for Carrier Diseases Product and Solutions
Table 8. Thermo Fisher Scientific Genetic Screening for Carrier Diseases Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. Thermo Fisher Scientific Recent Developments and Future Plans
Table 10. Eurofins Scientific Company Information, Head Office, and Major Competitors
Table 11. Eurofins Scientific Major Business
Table 12. Eurofins Scientific Genetic Screening for Carrier Diseases Product and Solutions
Table 13. Eurofins Scientific Genetic Screening for Carrier Diseases Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. Eurofins Scientific Recent Developments and Future Plans
Table 15. Illumina Company Information, Head Office, and Major Competitors
Table 16. Illumina Major Business
Table 17. Illumina Genetic Screening for Carrier Diseases Product and Solutions
Table 18. Illumina Genetic Screening for Carrier Diseases Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. Illumina Recent Developments and Future Plans
Table 20. Invitae Company Information, Head Office, and Major Competitors
Table 21. Invitae Major Business
Table 22. Invitae Genetic Screening for Carrier Diseases Product and Solutions
Table 23. Invitae Genetic Screening for Carrier Diseases Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 24. Invitae Recent Developments and Future Plans
Table 25. MedGenome Company Information, Head Office, and Major Competitors
Table 26. MedGenome Major Business
Table 27. MedGenome Genetic Screening for Carrier Diseases Product and Solutions
Table 28. MedGenome Genetic Screening for Carrier Diseases Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 29. MedGenome Recent Developments and Future Plans
Table 30. Myriad Genetics Company Information, Head Office, and Major Competitors
Table 31. Myriad Genetics Major Business
Table 32. Myriad Genetics Genetic Screening for Carrier Diseases Product and Solutions
Table 33. Myriad Genetics Genetic Screening for Carrier Diseases Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 34. Myriad Genetics Recent Developments and Future Plans
Table 35. Roche Company Information, Head Office, and Major Competitors
Table 36. Roche Major Business
Table 37. Roche Genetic Screening for Carrier Diseases Product and Solutions
Table 38. Roche Genetic Screening for Carrier Diseases Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 39. Roche Recent Developments and Future Plans
Table 40. Natera Company Information, Head Office, and Major Competitors
Table 41. Natera Major Business
Table 42. Natera Genetic Screening for Carrier Diseases Product and Solutions
Table 43. Natera Genetic Screening for Carrier Diseases Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 44. Natera Recent Developments and Future Plans
Table 45. OPKO Health Company Information, Head Office, and Major Competitors
Table 46. OPKO Health Major Business
Table 47. OPKO Health Genetic Screening for Carrier Diseases Product and Solutions
Table 48. OPKO Health Genetic Screening for Carrier Diseases Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 49. OPKO Health Recent Developments and Future Plans
Table 50. 23andMe Company Information, Head Office, and Major Competitors
Table 51. 23andMe Major Business
Table 52. 23andMe Genetic Screening for Carrier Diseases Product and Solutions
Table 53. 23andMe Genetic Screening for Carrier Diseases Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 54. 23andMe Recent Developments and Future Plans
Table 55. bioMйrieux Company Information, Head Office, and Major Competitors
Table 56. bioMйrieux Major Business
Table 57. bioMйrieux Genetic Screening for Carrier Diseases Product and Solutions
Table 58. bioMйrieux Genetic Screening for Carrier Diseases Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 59. bioMйrieux Recent Developments and Future Plans
Table 60. EKF Diagnostics Company Information, Head Office, and Major Competitors
Table 61. EKF Diagnostics Major Business
Table 62. EKF Diagnostics Genetic Screening for Carrier Diseases Product and Solutions
Table 63. EKF Diagnostics Genetic Screening for Carrier Diseases Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 64. EKF Diagnostics Recent Developments and Future Plans
Table 65. Gene by Gene (myDNA) Company Information, Head Office, and Major Competitors
Table 66. Gene by Gene (myDNA) Major Business
Table 67. Gene by Gene (myDNA) Genetic Screening for Carrier Diseases Product and Solutions
Table 68. Gene by Gene (myDNA) Genetic Screening for Carrier Diseases Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 69. Gene by Gene (myDNA) Recent Developments and Future Plans
Table 70. Fulgent Genetics Company Information, Head Office, and Major Competitors
Table 71. Fulgent Genetics Major Business
Table 72. Fulgent Genetics Genetic Screening for Carrier Diseases Product and Solutions
Table 73. Fulgent Genetics Genetic Screening for Carrier Diseases Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 74. Fulgent Genetics Recent Developments and Future Plans
Table 75. NxGen MDx Company Information, Head Office, and Major Competitors
Table 76. NxGen MDx Major Business
Table 77. NxGen MDx Genetic Screening for Carrier Diseases Product and Solutions
Table 78. NxGen MDx Genetic Screening for Carrier Diseases Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 79. NxGen MDx Recent Developments and Future Plans
Table 80. Sonic Genetics Company Information, Head Office, and Major Competitors
Table 81. Sonic Genetics Major Business
Table 82. Sonic Genetics Genetic Screening for Carrier Diseases Product and Solutions
Table 83. Sonic Genetics Genetic Screening for Carrier Diseases Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 84. Sonic Genetics Recent Developments and Future Plans
Table 85. My Baby Company Information, Head Office, and Major Competitors
Table 86. My Baby Major Business
Table 87. My Baby Genetic Screening for Carrier Diseases Product and Solutions
Table 88. My Baby Genetic Screening for Carrier Diseases Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 89. My Baby Recent Developments and Future Plans
Table 90. AncestryDNA Company Information, Head Office, and Major Competitors
Table 91. AncestryDNA Major Business
Table 92. AncestryDNA Genetic Screening for Carrier Diseases Product and Solutions
Table 93. AncestryDNA Genetic Screening for Carrier Diseases Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 94. AncestryDNA Recent Developments and Future Plans
Table 95. DiaSorin Company Information, Head Office, and Major Competitors
Table 96. DiaSorin Major Business
Table 97. DiaSorin Genetic Screening for Carrier Diseases Product and Solutions
Table 98. DiaSorin Genetic Screening for Carrier Diseases Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 99. DiaSorin Recent Developments and Future Plans
Table 100. Grifols Company Information, Head Office, and Major Competitors
Table 101. Grifols Major Business
Table 102. Grifols Genetic Screening for Carrier Diseases Product and Solutions
Table 103. Grifols Genetic Screening for Carrier Diseases Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 104. Grifols Recent Developments and Future Plans
Table 105. BGI Genomics Company Information, Head Office, and Major Competitors
Table 106. BGI Genomics Major Business
Table 107. BGI Genomics Genetic Screening for Carrier Diseases Product and Solutions
Table 108. BGI Genomics Genetic Screening for Carrier Diseases Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 109. BGI Genomics Recent Developments and Future Plans
Table 110. Chigene Company Information, Head Office, and Major Competitors
Table 111. Chigene Major Business
Table 112. Chigene Genetic Screening for Carrier Diseases Product and Solutions
Table 113. Chigene Genetic Screening for Carrier Diseases Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 114. Chigene Recent Developments and Future Plans
Table 115. Jiajian Medical Testing Company Information, Head Office, and Major Competitors
Table 116. Jiajian Medical Testing Major Business
Table 117. Jiajian Medical Testing Genetic Screening for Carrier Diseases Product and Solutions
Table 118. Jiajian Medical Testing Genetic Screening for Carrier Diseases Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 119. Jiajian Medical Testing Recent Developments and Future Plans
Table 120. Genesky Company Information, Head Office, and Major Competitors
Table 121. Genesky Major Business
Table 122. Genesky Genetic Screening for Carrier Diseases Product and Solutions
Table 123. Genesky Genetic Screening for Carrier Diseases Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 124. Genesky Recent Developments and Future Plans
Table 125. Berry Genomics Company Information, Head Office, and Major Competitors
Table 126. Berry Genomics Major Business
Table 127. Berry Genomics Genetic Screening for Carrier Diseases Product and Solutions
Table 128. Berry Genomics Genetic Screening for Carrier Diseases Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 129. Berry Genomics Recent Developments and Future Plans
Table 130. Weihansi Biomedical Technology Company Information, Head Office, and Major Competitors
Table 131. Weihansi Biomedical Technology Major Business
Table 132. Weihansi Biomedical Technology Genetic Screening for Carrier Diseases Product and Solutions
Table 133. Weihansi Biomedical Technology Genetic Screening for Carrier Diseases Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 134. Weihansi Biomedical Technology Recent Developments and Future Plans
Table 135. Annaroad Company Information, Head Office, and Major Competitors
Table 136. Annaroad Major Business
Table 137. Annaroad Genetic Screening for Carrier Diseases Product and Solutions
Table 138. Annaroad Genetic Screening for Carrier Diseases Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 139. Annaroad Recent Developments and Future Plans
Table 140. Global Genetic Screening for Carrier Diseases Revenue (USD Million) by Players (2019-2024)
Table 141. Global Genetic Screening for Carrier Diseases Revenue Share by Players (2019-2024)
Table 142. Breakdown of Genetic Screening for Carrier Diseases by Company Type (Tier 1, Tier 2, and Tier 3)
Table 143. Market Position of Players in Genetic Screening for Carrier Diseases, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 144. Head Office of Key Genetic Screening for Carrier Diseases Players
Table 145. Genetic Screening for Carrier Diseases Market: Company Product Type Footprint
Table 146. Genetic Screening for Carrier Diseases Market: Company Product Application Footprint
Table 147. Genetic Screening for Carrier Diseases New Market Entrants and Barriers to Market Entry
Table 148. Genetic Screening for Carrier Diseases Mergers, Acquisition, Agreements, and Collaborations
Table 149. Global Genetic Screening for Carrier Diseases Consumption Value (USD Million) by Type (2019-2024)
Table 150. Global Genetic Screening for Carrier Diseases Consumption Value Share by Type (2019-2024)
Table 151. Global Genetic Screening for Carrier Diseases Consumption Value Forecast by Type (2025-2030)
Table 152. Global Genetic Screening for Carrier Diseases Consumption Value by Application (2019-2024)
Table 153. Global Genetic Screening for Carrier Diseases Consumption Value Forecast by Application (2025-2030)
Table 154. North America Genetic Screening for Carrier Diseases Consumption Value by Type (2019-2024) & (USD Million)
Table 155. North America Genetic Screening for Carrier Diseases Consumption Value by Type (2025-2030) & (USD Million)
Table 156. North America Genetic Screening for Carrier Diseases Consumption Value by Application (2019-2024) & (USD Million)
Table 157. North America Genetic Screening for Carrier Diseases Consumption Value by Application (2025-2030) & (USD Million)
Table 158. North America Genetic Screening for Carrier Diseases Consumption Value by Country (2019-2024) & (USD Million)
Table 159. North America Genetic Screening for Carrier Diseases Consumption Value by Country (2025-2030) & (USD Million)
Table 160. Europe Genetic Screening for Carrier Diseases Consumption Value by Type (2019-2024) & (USD Million)
Table 161. Europe Genetic Screening for Carrier Diseases Consumption Value by Type (2025-2030) & (USD Million)
Table 162. Europe Genetic Screening for Carrier Diseases Consumption Value by Application (2019-2024) & (USD Million)
Table 163. Europe Genetic Screening for Carrier Diseases Consumption Value by Application (2025-2030) & (USD Million)
Table 164. Europe Genetic Screening for Carrier Diseases Consumption Value by Country (2019-2024) & (USD Million)
Table 165. Europe Genetic Screening for Carrier Diseases Consumption Value by Country (2025-2030) & (USD Million)
Table 166. Asia-Pacific Genetic Screening for Carrier Diseases Consumption Value by Type (2019-2024) & (USD Million)
Table 167. Asia-Pacific Genetic Screening for Carrier Diseases Consumption Value by Type (2025-2030) & (USD Million)
Table 168. Asia-Pacific Genetic Screening for Carrier Diseases Consumption Value by Application (2019-2024) & (USD Million)
Table 169. Asia-Pacific Genetic Screening for Carrier Diseases Consumption Value by Application (2025-2030) & (USD Million)
Table 170. Asia-Pacific Genetic Screening for Carrier Diseases Consumption Value by Region (2019-2024) & (USD Million)
Table 171. Asia-Pacific Genetic Screening for Carrier Diseases Consumption Value by Region (2025-2030) & (USD Million)
Table 172. South America Genetic Screening for Carrier Diseases Consumption Value by Type (2019-2024) & (USD Million)
Table 173. South America Genetic Screening for Carrier Diseases Consumption Value by Type (2025-2030) & (USD Million)
Table 174. South America Genetic Screening for Carrier Diseases Consumption Value by Application (2019-2024) & (USD Million)
Table 175. South America Genetic Screening for Carrier Diseases Consumption Value by Application (2025-2030) & (USD Million)
Table 176. South America Genetic Screening for Carrier Diseases Consumption Value by Country (2019-2024) & (USD Million)
Table 177. South America Genetic Screening for Carrier Diseases Consumption Value by Country (2025-2030) & (USD Million)
Table 178. Middle East & Africa Genetic Screening for Carrier Diseases Consumption Value by Type (2019-2024) & (USD Million)
Table 179. Middle East & Africa Genetic Screening for Carrier Diseases Consumption Value by Type (2025-2030) & (USD Million)
Table 180. Middle East & Africa Genetic Screening for Carrier Diseases Consumption Value by Application (2019-2024) & (USD Million)
Table 181. Middle East & Africa Genetic Screening for Carrier Diseases Consumption Value by Application (2025-2030) & (USD Million)
Table 182. Middle East & Africa Genetic Screening for Carrier Diseases Consumption Value by Country (2019-2024) & (USD Million)
Table 183. Middle East & Africa Genetic Screening for Carrier Diseases Consumption Value by Country (2025-2030) & (USD Million)
Table 184. Genetic Screening for Carrier Diseases Raw Material
Table 185. Key Suppliers of Genetic Screening for Carrier Diseases Raw Materials
Table 1. Global Genetic Screening for Carrier Diseases Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Genetic Screening for Carrier Diseases Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Global Genetic Screening for Carrier Diseases Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global Genetic Screening for Carrier Diseases Consumption Value by Region (2025-2030) & (USD Million)
Table 5. Thermo Fisher Scientific Company Information, Head Office, and Major Competitors
Table 6. Thermo Fisher Scientific Major Business
Table 7. Thermo Fisher Scientific Genetic Screening for Carrier Diseases Product and Solutions
Table 8. Thermo Fisher Scientific Genetic Screening for Carrier Diseases Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. Thermo Fisher Scientific Recent Developments and Future Plans
Table 10. Eurofins Scientific Company Information, Head Office, and Major Competitors
Table 11. Eurofins Scientific Major Business
Table 12. Eurofins Scientific Genetic Screening for Carrier Diseases Product and Solutions
Table 13. Eurofins Scientific Genetic Screening for Carrier Diseases Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. Eurofins Scientific Recent Developments and Future Plans
Table 15. Illumina Company Information, Head Office, and Major Competitors
Table 16. Illumina Major Business
Table 17. Illumina Genetic Screening for Carrier Diseases Product and Solutions
Table 18. Illumina Genetic Screening for Carrier Diseases Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. Illumina Recent Developments and Future Plans
Table 20. Invitae Company Information, Head Office, and Major Competitors
Table 21. Invitae Major Business
Table 22. Invitae Genetic Screening for Carrier Diseases Product and Solutions
Table 23. Invitae Genetic Screening for Carrier Diseases Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 24. Invitae Recent Developments and Future Plans
Table 25. MedGenome Company Information, Head Office, and Major Competitors
Table 26. MedGenome Major Business
Table 27. MedGenome Genetic Screening for Carrier Diseases Product and Solutions
Table 28. MedGenome Genetic Screening for Carrier Diseases Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 29. MedGenome Recent Developments and Future Plans
Table 30. Myriad Genetics Company Information, Head Office, and Major Competitors
Table 31. Myriad Genetics Major Business
Table 32. Myriad Genetics Genetic Screening for Carrier Diseases Product and Solutions
Table 33. Myriad Genetics Genetic Screening for Carrier Diseases Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 34. Myriad Genetics Recent Developments and Future Plans
Table 35. Roche Company Information, Head Office, and Major Competitors
Table 36. Roche Major Business
Table 37. Roche Genetic Screening for Carrier Diseases Product and Solutions
Table 38. Roche Genetic Screening for Carrier Diseases Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 39. Roche Recent Developments and Future Plans
Table 40. Natera Company Information, Head Office, and Major Competitors
Table 41. Natera Major Business
Table 42. Natera Genetic Screening for Carrier Diseases Product and Solutions
Table 43. Natera Genetic Screening for Carrier Diseases Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 44. Natera Recent Developments and Future Plans
Table 45. OPKO Health Company Information, Head Office, and Major Competitors
Table 46. OPKO Health Major Business
Table 47. OPKO Health Genetic Screening for Carrier Diseases Product and Solutions
Table 48. OPKO Health Genetic Screening for Carrier Diseases Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 49. OPKO Health Recent Developments and Future Plans
Table 50. 23andMe Company Information, Head Office, and Major Competitors
Table 51. 23andMe Major Business
Table 52. 23andMe Genetic Screening for Carrier Diseases Product and Solutions
Table 53. 23andMe Genetic Screening for Carrier Diseases Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 54. 23andMe Recent Developments and Future Plans
Table 55. bioMйrieux Company Information, Head Office, and Major Competitors
Table 56. bioMйrieux Major Business
Table 57. bioMйrieux Genetic Screening for Carrier Diseases Product and Solutions
Table 58. bioMйrieux Genetic Screening for Carrier Diseases Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 59. bioMйrieux Recent Developments and Future Plans
Table 60. EKF Diagnostics Company Information, Head Office, and Major Competitors
Table 61. EKF Diagnostics Major Business
Table 62. EKF Diagnostics Genetic Screening for Carrier Diseases Product and Solutions
Table 63. EKF Diagnostics Genetic Screening for Carrier Diseases Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 64. EKF Diagnostics Recent Developments and Future Plans
Table 65. Gene by Gene (myDNA) Company Information, Head Office, and Major Competitors
Table 66. Gene by Gene (myDNA) Major Business
Table 67. Gene by Gene (myDNA) Genetic Screening for Carrier Diseases Product and Solutions
Table 68. Gene by Gene (myDNA) Genetic Screening for Carrier Diseases Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 69. Gene by Gene (myDNA) Recent Developments and Future Plans
Table 70. Fulgent Genetics Company Information, Head Office, and Major Competitors
Table 71. Fulgent Genetics Major Business
Table 72. Fulgent Genetics Genetic Screening for Carrier Diseases Product and Solutions
Table 73. Fulgent Genetics Genetic Screening for Carrier Diseases Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 74. Fulgent Genetics Recent Developments and Future Plans
Table 75. NxGen MDx Company Information, Head Office, and Major Competitors
Table 76. NxGen MDx Major Business
Table 77. NxGen MDx Genetic Screening for Carrier Diseases Product and Solutions
Table 78. NxGen MDx Genetic Screening for Carrier Diseases Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 79. NxGen MDx Recent Developments and Future Plans
Table 80. Sonic Genetics Company Information, Head Office, and Major Competitors
Table 81. Sonic Genetics Major Business
Table 82. Sonic Genetics Genetic Screening for Carrier Diseases Product and Solutions
Table 83. Sonic Genetics Genetic Screening for Carrier Diseases Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 84. Sonic Genetics Recent Developments and Future Plans
Table 85. My Baby Company Information, Head Office, and Major Competitors
Table 86. My Baby Major Business
Table 87. My Baby Genetic Screening for Carrier Diseases Product and Solutions
Table 88. My Baby Genetic Screening for Carrier Diseases Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 89. My Baby Recent Developments and Future Plans
Table 90. AncestryDNA Company Information, Head Office, and Major Competitors
Table 91. AncestryDNA Major Business
Table 92. AncestryDNA Genetic Screening for Carrier Diseases Product and Solutions
Table 93. AncestryDNA Genetic Screening for Carrier Diseases Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 94. AncestryDNA Recent Developments and Future Plans
Table 95. DiaSorin Company Information, Head Office, and Major Competitors
Table 96. DiaSorin Major Business
Table 97. DiaSorin Genetic Screening for Carrier Diseases Product and Solutions
Table 98. DiaSorin Genetic Screening for Carrier Diseases Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 99. DiaSorin Recent Developments and Future Plans
Table 100. Grifols Company Information, Head Office, and Major Competitors
Table 101. Grifols Major Business
Table 102. Grifols Genetic Screening for Carrier Diseases Product and Solutions
Table 103. Grifols Genetic Screening for Carrier Diseases Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 104. Grifols Recent Developments and Future Plans
Table 105. BGI Genomics Company Information, Head Office, and Major Competitors
Table 106. BGI Genomics Major Business
Table 107. BGI Genomics Genetic Screening for Carrier Diseases Product and Solutions
Table 108. BGI Genomics Genetic Screening for Carrier Diseases Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 109. BGI Genomics Recent Developments and Future Plans
Table 110. Chigene Company Information, Head Office, and Major Competitors
Table 111. Chigene Major Business
Table 112. Chigene Genetic Screening for Carrier Diseases Product and Solutions
Table 113. Chigene Genetic Screening for Carrier Diseases Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 114. Chigene Recent Developments and Future Plans
Table 115. Jiajian Medical Testing Company Information, Head Office, and Major Competitors
Table 116. Jiajian Medical Testing Major Business
Table 117. Jiajian Medical Testing Genetic Screening for Carrier Diseases Product and Solutions
Table 118. Jiajian Medical Testing Genetic Screening for Carrier Diseases Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 119. Jiajian Medical Testing Recent Developments and Future Plans
Table 120. Genesky Company Information, Head Office, and Major Competitors
Table 121. Genesky Major Business
Table 122. Genesky Genetic Screening for Carrier Diseases Product and Solutions
Table 123. Genesky Genetic Screening for Carrier Diseases Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 124. Genesky Recent Developments and Future Plans
Table 125. Berry Genomics Company Information, Head Office, and Major Competitors
Table 126. Berry Genomics Major Business
Table 127. Berry Genomics Genetic Screening for Carrier Diseases Product and Solutions
Table 128. Berry Genomics Genetic Screening for Carrier Diseases Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 129. Berry Genomics Recent Developments and Future Plans
Table 130. Weihansi Biomedical Technology Company Information, Head Office, and Major Competitors
Table 131. Weihansi Biomedical Technology Major Business
Table 132. Weihansi Biomedical Technology Genetic Screening for Carrier Diseases Product and Solutions
Table 133. Weihansi Biomedical Technology Genetic Screening for Carrier Diseases Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 134. Weihansi Biomedical Technology Recent Developments and Future Plans
Table 135. Annaroad Company Information, Head Office, and Major Competitors
Table 136. Annaroad Major Business
Table 137. Annaroad Genetic Screening for Carrier Diseases Product and Solutions
Table 138. Annaroad Genetic Screening for Carrier Diseases Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 139. Annaroad Recent Developments and Future Plans
Table 140. Global Genetic Screening for Carrier Diseases Revenue (USD Million) by Players (2019-2024)
Table 141. Global Genetic Screening for Carrier Diseases Revenue Share by Players (2019-2024)
Table 142. Breakdown of Genetic Screening for Carrier Diseases by Company Type (Tier 1, Tier 2, and Tier 3)
Table 143. Market Position of Players in Genetic Screening for Carrier Diseases, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 144. Head Office of Key Genetic Screening for Carrier Diseases Players
Table 145. Genetic Screening for Carrier Diseases Market: Company Product Type Footprint
Table 146. Genetic Screening for Carrier Diseases Market: Company Product Application Footprint
Table 147. Genetic Screening for Carrier Diseases New Market Entrants and Barriers to Market Entry
Table 148. Genetic Screening for Carrier Diseases Mergers, Acquisition, Agreements, and Collaborations
Table 149. Global Genetic Screening for Carrier Diseases Consumption Value (USD Million) by Type (2019-2024)
Table 150. Global Genetic Screening for Carrier Diseases Consumption Value Share by Type (2019-2024)
Table 151. Global Genetic Screening for Carrier Diseases Consumption Value Forecast by Type (2025-2030)
Table 152. Global Genetic Screening for Carrier Diseases Consumption Value by Application (2019-2024)
Table 153. Global Genetic Screening for Carrier Diseases Consumption Value Forecast by Application (2025-2030)
Table 154. North America Genetic Screening for Carrier Diseases Consumption Value by Type (2019-2024) & (USD Million)
Table 155. North America Genetic Screening for Carrier Diseases Consumption Value by Type (2025-2030) & (USD Million)
Table 156. North America Genetic Screening for Carrier Diseases Consumption Value by Application (2019-2024) & (USD Million)
Table 157. North America Genetic Screening for Carrier Diseases Consumption Value by Application (2025-2030) & (USD Million)
Table 158. North America Genetic Screening for Carrier Diseases Consumption Value by Country (2019-2024) & (USD Million)
Table 159. North America Genetic Screening for Carrier Diseases Consumption Value by Country (2025-2030) & (USD Million)
Table 160. Europe Genetic Screening for Carrier Diseases Consumption Value by Type (2019-2024) & (USD Million)
Table 161. Europe Genetic Screening for Carrier Diseases Consumption Value by Type (2025-2030) & (USD Million)
Table 162. Europe Genetic Screening for Carrier Diseases Consumption Value by Application (2019-2024) & (USD Million)
Table 163. Europe Genetic Screening for Carrier Diseases Consumption Value by Application (2025-2030) & (USD Million)
Table 164. Europe Genetic Screening for Carrier Diseases Consumption Value by Country (2019-2024) & (USD Million)
Table 165. Europe Genetic Screening for Carrier Diseases Consumption Value by Country (2025-2030) & (USD Million)
Table 166. Asia-Pacific Genetic Screening for Carrier Diseases Consumption Value by Type (2019-2024) & (USD Million)
Table 167. Asia-Pacific Genetic Screening for Carrier Diseases Consumption Value by Type (2025-2030) & (USD Million)
Table 168. Asia-Pacific Genetic Screening for Carrier Diseases Consumption Value by Application (2019-2024) & (USD Million)
Table 169. Asia-Pacific Genetic Screening for Carrier Diseases Consumption Value by Application (2025-2030) & (USD Million)
Table 170. Asia-Pacific Genetic Screening for Carrier Diseases Consumption Value by Region (2019-2024) & (USD Million)
Table 171. Asia-Pacific Genetic Screening for Carrier Diseases Consumption Value by Region (2025-2030) & (USD Million)
Table 172. South America Genetic Screening for Carrier Diseases Consumption Value by Type (2019-2024) & (USD Million)
Table 173. South America Genetic Screening for Carrier Diseases Consumption Value by Type (2025-2030) & (USD Million)
Table 174. South America Genetic Screening for Carrier Diseases Consumption Value by Application (2019-2024) & (USD Million)
Table 175. South America Genetic Screening for Carrier Diseases Consumption Value by Application (2025-2030) & (USD Million)
Table 176. South America Genetic Screening for Carrier Diseases Consumption Value by Country (2019-2024) & (USD Million)
Table 177. South America Genetic Screening for Carrier Diseases Consumption Value by Country (2025-2030) & (USD Million)
Table 178. Middle East & Africa Genetic Screening for Carrier Diseases Consumption Value by Type (2019-2024) & (USD Million)
Table 179. Middle East & Africa Genetic Screening for Carrier Diseases Consumption Value by Type (2025-2030) & (USD Million)
Table 180. Middle East & Africa Genetic Screening for Carrier Diseases Consumption Value by Application (2019-2024) & (USD Million)
Table 181. Middle East & Africa Genetic Screening for Carrier Diseases Consumption Value by Application (2025-2030) & (USD Million)
Table 182. Middle East & Africa Genetic Screening for Carrier Diseases Consumption Value by Country (2019-2024) & (USD Million)
Table 183. Middle East & Africa Genetic Screening for Carrier Diseases Consumption Value by Country (2025-2030) & (USD Million)
Table 184. Genetic Screening for Carrier Diseases Raw Material
Table 185. Key Suppliers of Genetic Screening for Carrier Diseases Raw Materials
LIST OF FIGURES
Figure 1. Genetic Screening for Carrier Diseases Picture
Figure 2. Global Genetic Screening for Carrier Diseases Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Genetic Screening for Carrier Diseases Consumption Value Market Share by Type in 2023
Figure 4. NGS
Figure 5. Whole Exome Sequencing
Figure 6. Others
Figure 7. Global Genetic Screening for Carrier Diseases Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 8. Genetic Screening for Carrier Diseases Consumption Value Market Share by Application in 2023
Figure 9. Couple Picture
Figure 10. Individual Picture
Figure 11. Global Genetic Screening for Carrier Diseases Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 12. Global Genetic Screening for Carrier Diseases Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 13. Global Market Genetic Screening for Carrier Diseases Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
Figure 14. Global Genetic Screening for Carrier Diseases Consumption Value Market Share by Region (2019-2030)
Figure 15. Global Genetic Screening for Carrier Diseases Consumption Value Market Share by Region in 2023
Figure 16. North America Genetic Screening for Carrier Diseases Consumption Value (2019-2030) & (USD Million)
Figure 17. Europe Genetic Screening for Carrier Diseases Consumption Value (2019-2030) & (USD Million)
Figure 18. Asia-Pacific Genetic Screening for Carrier Diseases Consumption Value (2019-2030) & (USD Million)
Figure 19. South America Genetic Screening for Carrier Diseases Consumption Value (2019-2030) & (USD Million)
Figure 20. Middle East and Africa Genetic Screening for Carrier Diseases Consumption Value (2019-2030) & (USD Million)
Figure 21. Global Genetic Screening for Carrier Diseases Revenue Share by Players in 2023
Figure 22. Genetic Screening for Carrier Diseases Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
Figure 23. Global Top 3 Players Genetic Screening for Carrier Diseases Market Share in 2023
Figure 24. Global Top 6 Players Genetic Screening for Carrier Diseases Market Share in 2023
Figure 25. Global Genetic Screening for Carrier Diseases Consumption Value Share by Type (2019-2024)
Figure 26. Global Genetic Screening for Carrier Diseases Market Share Forecast by Type (2025-2030)
Figure 27. Global Genetic Screening for Carrier Diseases Consumption Value Share by Application (2019-2024)
Figure 28. Global Genetic Screening for Carrier Diseases Market Share Forecast by Application (2025-2030)
Figure 29. North America Genetic Screening for Carrier Diseases Consumption Value Market Share by Type (2019-2030)
Figure 30. North America Genetic Screening for Carrier Diseases Consumption Value Market Share by Application (2019-2030)
Figure 31. North America Genetic Screening for Carrier Diseases Consumption Value Market Share by Country (2019-2030)
Figure 32. United States Genetic Screening for Carrier Diseases Consumption Value (2019-2030) & (USD Million)
Figure 33. Canada Genetic Screening for Carrier Diseases Consumption Value (2019-2030) & (USD Million)
Figure 34. Mexico Genetic Screening for Carrier Diseases Consumption Value (2019-2030) & (USD Million)
Figure 35. Europe Genetic Screening for Carrier Diseases Consumption Value Market Share by Type (2019-2030)
Figure 36. Europe Genetic Screening for Carrier Diseases Consumption Value Market Share by Application (2019-2030)
Figure 37. Europe Genetic Screening for Carrier Diseases Consumption Value Market Share by Country (2019-2030)
Figure 38. Germany Genetic Screening for Carrier Diseases Consumption Value (2019-2030) & (USD Million)
Figure 39. France Genetic Screening for Carrier Diseases Consumption Value (2019-2030) & (USD Million)
Figure 40. United Kingdom Genetic Screening for Carrier Diseases Consumption Value (2019-2030) & (USD Million)
Figure 41. Russia Genetic Screening for Carrier Diseases Consumption Value (2019-2030) & (USD Million)
Figure 42. Italy Genetic Screening for Carrier Diseases Consumption Value (2019-2030) & (USD Million)
Figure 43. Asia-Pacific Genetic Screening for Carrier Diseases Consumption Value Market Share by Type (2019-2030)
Figure 44. Asia-Pacific Genetic Screening for Carrier Diseases Consumption Value Market Share by Application (2019-2030)
Figure 45. Asia-Pacific Genetic Screening for Carrier Diseases Consumption Value Market Share by Region (2019-2030)
Figure 46. China Genetic Screening for Carrier Diseases Consumption Value (2019-2030) & (USD Million)
Figure 47. Japan Genetic Screening for Carrier Diseases Consumption Value (2019-2030) & (USD Million)
Figure 48. South Korea Genetic Screening for Carrier Diseases Consumption Value (2019-2030) & (USD Million)
Figure 49. India Genetic Screening for Carrier Diseases Consumption Value (2019-2030) & (USD Million)
Figure 50. Southeast Asia Genetic Screening for Carrier Diseases Consumption Value (2019-2030) & (USD Million)
Figure 51. Australia Genetic Screening for Carrier Diseases Consumption Value (2019-2030) & (USD Million)
Figure 52. South America Genetic Screening for Carrier Diseases Consumption Value Market Share by Type (2019-2030)
Figure 53. South America Genetic Screening for Carrier Diseases Consumption Value Market Share by Application (2019-2030)
Figure 54. South America Genetic Screening for Carrier Diseases Consumption Value Market Share by Country (2019-2030)
Figure 55. Brazil Genetic Screening for Carrier Diseases Consumption Value (2019-2030) & (USD Million)
Figure 56. Argentina Genetic Screening for Carrier Diseases Consumption Value (2019-2030) & (USD Million)
Figure 57. Middle East and Africa Genetic Screening for Carrier Diseases Consumption Value Market Share by Type (2019-2030)
Figure 58. Middle East and Africa Genetic Screening for Carrier Diseases Consumption Value Market Share by Application (2019-2030)
Figure 59. Middle East and Africa Genetic Screening for Carrier Diseases Consumption Value Market Share by Country (2019-2030)
Figure 60. Turkey Genetic Screening for Carrier Diseases Consumption Value (2019-2030) & (USD Million)
Figure 61. Saudi Arabia Genetic Screening for Carrier Diseases Consumption Value (2019-2030) & (USD Million)
Figure 62. UAE Genetic Screening for Carrier Diseases Consumption Value (2019-2030) & (USD Million)
Figure 63. Genetic Screening for Carrier Diseases Market Drivers
Figure 64. Genetic Screening for Carrier Diseases Market Restraints
Figure 65. Genetic Screening for Carrier Diseases Market Trends
Figure 66. Porters Five Forces Analysis
Figure 67. Manufacturing Cost Structure Analysis of Genetic Screening for Carrier Diseases in 2023
Figure 68. Manufacturing Process Analysis of Genetic Screening for Carrier Diseases
Figure 69. Genetic Screening for Carrier Diseases Industrial Chain
Figure 70. Methodology
Figure 71. Research Process and Data Source
Figure 1. Genetic Screening for Carrier Diseases Picture
Figure 2. Global Genetic Screening for Carrier Diseases Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Genetic Screening for Carrier Diseases Consumption Value Market Share by Type in 2023
Figure 4. NGS
Figure 5. Whole Exome Sequencing
Figure 6. Others
Figure 7. Global Genetic Screening for Carrier Diseases Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 8. Genetic Screening for Carrier Diseases Consumption Value Market Share by Application in 2023
Figure 9. Couple Picture
Figure 10. Individual Picture
Figure 11. Global Genetic Screening for Carrier Diseases Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 12. Global Genetic Screening for Carrier Diseases Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 13. Global Market Genetic Screening for Carrier Diseases Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
Figure 14. Global Genetic Screening for Carrier Diseases Consumption Value Market Share by Region (2019-2030)
Figure 15. Global Genetic Screening for Carrier Diseases Consumption Value Market Share by Region in 2023
Figure 16. North America Genetic Screening for Carrier Diseases Consumption Value (2019-2030) & (USD Million)
Figure 17. Europe Genetic Screening for Carrier Diseases Consumption Value (2019-2030) & (USD Million)
Figure 18. Asia-Pacific Genetic Screening for Carrier Diseases Consumption Value (2019-2030) & (USD Million)
Figure 19. South America Genetic Screening for Carrier Diseases Consumption Value (2019-2030) & (USD Million)
Figure 20. Middle East and Africa Genetic Screening for Carrier Diseases Consumption Value (2019-2030) & (USD Million)
Figure 21. Global Genetic Screening for Carrier Diseases Revenue Share by Players in 2023
Figure 22. Genetic Screening for Carrier Diseases Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
Figure 23. Global Top 3 Players Genetic Screening for Carrier Diseases Market Share in 2023
Figure 24. Global Top 6 Players Genetic Screening for Carrier Diseases Market Share in 2023
Figure 25. Global Genetic Screening for Carrier Diseases Consumption Value Share by Type (2019-2024)
Figure 26. Global Genetic Screening for Carrier Diseases Market Share Forecast by Type (2025-2030)
Figure 27. Global Genetic Screening for Carrier Diseases Consumption Value Share by Application (2019-2024)
Figure 28. Global Genetic Screening for Carrier Diseases Market Share Forecast by Application (2025-2030)
Figure 29. North America Genetic Screening for Carrier Diseases Consumption Value Market Share by Type (2019-2030)
Figure 30. North America Genetic Screening for Carrier Diseases Consumption Value Market Share by Application (2019-2030)
Figure 31. North America Genetic Screening for Carrier Diseases Consumption Value Market Share by Country (2019-2030)
Figure 32. United States Genetic Screening for Carrier Diseases Consumption Value (2019-2030) & (USD Million)
Figure 33. Canada Genetic Screening for Carrier Diseases Consumption Value (2019-2030) & (USD Million)
Figure 34. Mexico Genetic Screening for Carrier Diseases Consumption Value (2019-2030) & (USD Million)
Figure 35. Europe Genetic Screening for Carrier Diseases Consumption Value Market Share by Type (2019-2030)
Figure 36. Europe Genetic Screening for Carrier Diseases Consumption Value Market Share by Application (2019-2030)
Figure 37. Europe Genetic Screening for Carrier Diseases Consumption Value Market Share by Country (2019-2030)
Figure 38. Germany Genetic Screening for Carrier Diseases Consumption Value (2019-2030) & (USD Million)
Figure 39. France Genetic Screening for Carrier Diseases Consumption Value (2019-2030) & (USD Million)
Figure 40. United Kingdom Genetic Screening for Carrier Diseases Consumption Value (2019-2030) & (USD Million)
Figure 41. Russia Genetic Screening for Carrier Diseases Consumption Value (2019-2030) & (USD Million)
Figure 42. Italy Genetic Screening for Carrier Diseases Consumption Value (2019-2030) & (USD Million)
Figure 43. Asia-Pacific Genetic Screening for Carrier Diseases Consumption Value Market Share by Type (2019-2030)
Figure 44. Asia-Pacific Genetic Screening for Carrier Diseases Consumption Value Market Share by Application (2019-2030)
Figure 45. Asia-Pacific Genetic Screening for Carrier Diseases Consumption Value Market Share by Region (2019-2030)
Figure 46. China Genetic Screening for Carrier Diseases Consumption Value (2019-2030) & (USD Million)
Figure 47. Japan Genetic Screening for Carrier Diseases Consumption Value (2019-2030) & (USD Million)
Figure 48. South Korea Genetic Screening for Carrier Diseases Consumption Value (2019-2030) & (USD Million)
Figure 49. India Genetic Screening for Carrier Diseases Consumption Value (2019-2030) & (USD Million)
Figure 50. Southeast Asia Genetic Screening for Carrier Diseases Consumption Value (2019-2030) & (USD Million)
Figure 51. Australia Genetic Screening for Carrier Diseases Consumption Value (2019-2030) & (USD Million)
Figure 52. South America Genetic Screening for Carrier Diseases Consumption Value Market Share by Type (2019-2030)
Figure 53. South America Genetic Screening for Carrier Diseases Consumption Value Market Share by Application (2019-2030)
Figure 54. South America Genetic Screening for Carrier Diseases Consumption Value Market Share by Country (2019-2030)
Figure 55. Brazil Genetic Screening for Carrier Diseases Consumption Value (2019-2030) & (USD Million)
Figure 56. Argentina Genetic Screening for Carrier Diseases Consumption Value (2019-2030) & (USD Million)
Figure 57. Middle East and Africa Genetic Screening for Carrier Diseases Consumption Value Market Share by Type (2019-2030)
Figure 58. Middle East and Africa Genetic Screening for Carrier Diseases Consumption Value Market Share by Application (2019-2030)
Figure 59. Middle East and Africa Genetic Screening for Carrier Diseases Consumption Value Market Share by Country (2019-2030)
Figure 60. Turkey Genetic Screening for Carrier Diseases Consumption Value (2019-2030) & (USD Million)
Figure 61. Saudi Arabia Genetic Screening for Carrier Diseases Consumption Value (2019-2030) & (USD Million)
Figure 62. UAE Genetic Screening for Carrier Diseases Consumption Value (2019-2030) & (USD Million)
Figure 63. Genetic Screening for Carrier Diseases Market Drivers
Figure 64. Genetic Screening for Carrier Diseases Market Restraints
Figure 65. Genetic Screening for Carrier Diseases Market Trends
Figure 66. Porters Five Forces Analysis
Figure 67. Manufacturing Cost Structure Analysis of Genetic Screening for Carrier Diseases in 2023
Figure 68. Manufacturing Process Analysis of Genetic Screening for Carrier Diseases
Figure 69. Genetic Screening for Carrier Diseases Industrial Chain
Figure 70. Methodology
Figure 71. Research Process and Data Source
